| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-07 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
| mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
| mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
| mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0001 |
| mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
| mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
0.0009 |